Concepedia

Melissa J. Ossanna

MJ

Statistics

Publications

5

Citations

669

H-Index

5

Active since

2006

Affiliations

Eli Lilly (United States)(Current)

Melissa J. Ossanna is an author at Eli Lilly (United States) specializing in duloxetine therapy, pharmacotherapy, and pharmacology.

Publications per year

2006–2010

5

Publications

5

Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial

Amy S. Chappell, Melissa J. Ossanna, Hong Liu‐Seifert et al. · Pain · 2009 · 300 citations

, , +17

A double‐blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain

Vladimir Skljarevski, Melissa J. Ossanna, Q Zhang et al. · European Journal of Neurology · 2009 · 165 citations

, , +16

A retrospective pooled analysis of duloxetine safety in 23 983 subjects

James Gahimer, Joachim Wernicke, Ilker Yalcin et al. · Current Medical Research and Opinion · 2006 · 101 citations

, , +17

Profile of Adverse Events with Duloxetine Treatment

Stephen Brunton, Fujun Wang, SJ Edwards et al. · Drug Safety · 2010 · 61 citations

, , +14

Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients

Ajay D. Wasan, Melissa J. Ossanna, Joel Raskin et al. · Current Drug Safety · 2009 · 42 citations

, , +17

1–5 of 5